Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Voyager Therapeutics, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Voyager Therapeutics announced its fourth quarter and full year 2025 financial results on March 9, 2026, providing stakeholders with key performance metrics and corporate updates that are essential for evaluating the company's operational status and strategic direction.
Key Takeaways
Company reported full year 2025 financial results including fourth quarter performance metrics
Corporate updates were provided alongside financial announcement to inform stakeholder decision-making
2 more takeaways
Related Filings (1)
1 more filing from Voyager Therapeutics, Inc. in the last 90 days